“With imports comprising as much as 70 to 90 percent of drugs consumed in most countries in sub-Saharan Africa, many governments are considering whether it’s time to promote more local production. Drug imports, including both over-the-counter and prescription drugs, do considerably exceed those into China and India—where comparable populations import around 5 percent and 20 percent, respectively. And it does put a strain on government and household budgets and already limited foreign exchanges.” – McKinsey
Answering the need on the continent, Kiara Health acquired a 52,000 m2 World-class Pharmaceutical Production Site.
The site is located very close to OR Tambo International Airport – the gateway to easy access into the rest of the African continent. WHO Certification in progress.
The Manufacturing Plant houses an Accredited Laboratory with best in class equipment & experienced staff. In addition, the site has a dedicated Manufacturing Science and Technology Team.
The acquisition of the facility included the retention of all staff highly-trained to multinational pharmaceutical manufacturing standards, with an average tenure of ± 20 years each.
The Kiara Health Manufacturing site has the capability to produce its own Marketing Authorised products as well as CMO.
Key manufacturing types:
Key Process Technologies:
Dry mixing, wet granulation, encapsulation, compression and coating (film-coated and sugar-coated)
Effervescence tablets, tablets / capsules, (polyvinyl chloride (PVC) / polyvinylidene chloride (PVDC) blisters, bottles) nasal sprays, eye drops, suppositories and ampoules / vials for injection/ infusion
Total warehousing capacity of 2,181 m2 temperature and humidity-controlled.
Warehousing capacity available for 3,000 pallets.
Capability to store up to Schedule 5 substances.
The Kiara Health Quality Assurance team is responsible for defining and executing systems and processes across the company that ensure that goods and services meet all quality, efficacy, and safety requirements. The Team is intricately involved to ensure that the highest quality standards for the following are met:
- New Product Planning
- Prototype Creation
- Process Design
- Trial Production
- After-Sales Service
Capability and capacity to do:
- Bulk manufacturing
- Primary Packaging
- Secondary Packaging
- Testing and Release Activities
- Cold Storage
- Capacity for ID and Assay Post-importation Testing on Oral Solid Dosage forms.
- 25°Celsius /60% RH
- 30°Celsius / 65% RH
- 40°Celsius /75% RH
- Stability housing of products.
- Accelerated, real-time stability studies.
- Stability Chambers linked to online EMS system.
- Dedicated and highly-skilled AS and T Team for Method Development and Transfer.
Cold Chain Storage
- 2 – 8°Celsius
- Capacity: 300 pallets
- Linked to EMS online monitoring system to maintain production integrity and quality
Expanding Access to Innovative Healthcare
Kiara Health has a wide geographic Pan African reach with ready market access through operations in three African hubs.
Our Executive Management Team, together with Imperial Logistics, has hands-on African Pharma experience, extensive networks and a demonstrated ability to execute in order to take your product into the continent.